Safety and Efficacy of Low-Dosage Apatinib Monotherapy in Advanced Lung Squamous-Cell Carcinoma: A Prospective Cohort Study

BACKGROUND: Lung squamous-cell carcinoma (SqCC) is the second most common histology in non-small-cell lung carcinomas (NSCLCs). The treatment options for advanced lung SqCC are still an unmet medical need. Apatinib, a small-molecule inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Qian, Shen, Hua, Zhu, Wenyu, Lu, Yingzhi, Wang, Mengjie, Jiang, Hua, Li, Dongqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667165/
https://www.ncbi.nlm.nih.gov/pubmed/33204107
http://dx.doi.org/10.2147/OTT.S277532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667165/
https://www.ncbi.nlm.nih.gov/pubmed/33204107
http://dx.doi.org/10.2147/OTT.S277532

Ejemplares similares